CHU La Timone
Département de Pharmacologie Clinique
Pr Olivier BLIN
Directeur du Centre de Pharmacologie Clinique et de Pharmacovigilance
Chargée de mission :
DHUNE has the full support of 7 local industrial partners (ICDD, Neuroservice, Neuron experts, Phénotype Expertise, Provetech, Vect-Horus) as well as large pharmaceutical companies (Ipsen, Sanofi) who have formally agreed to join the initiative and take part in the Dhune governance.
Moreover, DHUNE has established strong links with most of the companies involved in neurodegenerative diseases in the biomedical (Medtronic, Boston Scientific, Siemens, GE) and pharmaceutical sectors (Roche, Novartis, GSK, Servier, Teva, Astra Zeneca, Lundbeck, J & J, Boehringer Ingelheim, Eli Lilly).
This long-term collaboration with industrial partners favours technology transfer, revisions and improvements in the training programs, the launch of new clinical trials and the acceleration in marketing of the latest technology.
DHUNE also aims at developing new computerised tools (web interface, mobile applications) for the diagnosis, care and treatment of neurodegenerative diseases.